In today’s landscape of direct-to-consumer advertising, pharmacists are a vital source of guidance for both healthcare providers and patients seeking information on newly FDA-approved medications. Staying up-to-date on the latest drug approvals is crucial for pharmacists to ensure accurate dispensing and to offer thorough education to patients and other providers. This episode highlights several medications approved by the FDA in the last 12 to 18 months, providing essential insights into their clinical use.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJoe Strain, PharmDProfessor Pharmacy PracticeSouth Dakota State University Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. List unique pharmacological properties for each medication recently approved by the FDA.2. Recall common side effects, contraindications, known drug interactions, and/or warnings associated with each new medication.0.05 CEU/0.5 HrUAN: 0107-0000-24-267-H01-P Initial release date: 9/30/2024Expiration date: 9/30/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In an era where informed decisions are crucial to public health, understanding vaccine hesitancy has never been more critical. Listen in to this week’s GC episode to learn actionable steps you can make today to break down vaccine hesitancy barriers and provide an accurate and data-driven approach to vaccine education in your community.HOSTJen Moulton, BSPharmPresidentCEimpactGUESTLacy Epperson, PharmDDirector of Pharmacy Clinical ServicesMitchell's Drug Stores Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Analyze the underlying factors contributing to vaccine hesitancy and their effects on public health.2. Discuss effective communication and outreach strategies to increase vaccination rates within a pharmacys community.0.05 CEU/0.5 HrUAN: 0107-0000-24-262-H06-PInitial release date: 9/23/2024Expiration date: 9/23/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

According to the National Heart, Lung, and Blood Institute (NHLBI), 50–70 million Americans have sleep disorders, and one in three adults don't get enough uninterrupted sleep to maintain their health. Listen in to this week’s GC episode to learn the physiology of sleep, why we need sleep, and what our role is in educating patients on sleep hygiene sleep disorders, and OTC vs. Non-OTC options. HOSTJen Moulton, BSPharmPresidentCEimpactGUESTEzequiel Medina, PharmDSleep Coach and PharmacistLive Love SleepPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common sleep disorders and their impact on patient health and outcomes.2. Explain strategies for managing sleep disorders through pharmacological and non-pharmacological interventions in pharmacy practice.0.05 CEU/0.5 HrUAN: 0107-0000-24-263-H01-PInitial release date: 9/16/2024Expiration date: 9/16/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

A Community Health Worker (CHW) is a frontline public health worker who is a trusted member of the community they serve. CHWs act as a bridge between health and social services and the community, helping to improve health outcomes and access to care. Our goal during this episode is to discuss why training pharmacy technicians to step into the role of a Community Health Worker has been imperative to meeting the health equity demands in local communities. Jen Moulton, BSPharmPresidentCEimpactMeredith Ayers, CPhT-Adv, CHWDevelopment SpecialistBremo Pharmacy Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Evaluate the role and impact of pharmacy-placed Community Health Workers (CHWs) on patient outcomes and community health. 2. Describe a plan to integrate CHWs into pharmacy practice by cross-training pharmacy technicians. 0.05 CEU/0.5 HrUAN: 0107-0000-24-260-H04-PInitial release date: 9/9/2024Expiration date: 9/9/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN:  0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa Clinic ReferenceGuidelinesPaper Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Stigmatizing language may be part of our daily interactions with patients without even realizing it. It can appear in charts, regardless of race, gender, gender identity, ability, or socioeconomic status, but it has been found to occur more frequently for groups who are traditionally marginalized. How often do you reflect on the language you use with patients and how it might be interpreted by them, depending on their unique circumstances? And what are we doing as preceptors to help our residents and students understand the importance of language in their patient interactions? Listen in to learn more.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestKashelle Lockman, PharmD, MAClinical Associate ProfessorUniversity of IowaGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. List examples of stigmatizing language and its impact on pharmacist-patient interactions2. Describe strategies preceptors can use to foster the use of non-stigmatizing language by students and residents0.05 CEU/0.5 HrUAN: 0107-0000-24-250-H99-PInitial release date: 8/21/2024Expiration date: 8/21/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset. The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceThe recombinant shingles vaccine is associated with lower risk of dementia Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe dementia's epidemiology and the significance of preventive interventions.2. Discuss the strengths, weaknesses, and outcomes of the study.0.05 CEU/0.5 HrUAN: 0107-0000-24-246-H01-PInitial release date: 08/19/2024Expiration date: 08/19/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPrevious GameChangers on PREVENT score Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management. The GameChangerIncorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management. GuestsMark Smith, Jr., PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood, PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial Hospital Reference MaterialsThe Role of Exercise in DiabetesPhysical Activity and Diabetes Position from the ADASupplemental Continuing Education CoursesGlucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hrGuardians of the Glucose Galaxy: The Rise of CGMs - 1hr Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrsAdditional GameChangers EpisodesContinuous Glucose Monitors Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of physical fitness on diabetes management.2. Identify strategies for educating patients on exercise and diabetes.0.05 CEU/0.5 HrUAN: 0107-0000-24-224-H01-PInitial release date: 08/05/2024Expiration date: 08/05/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.  The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridad ReferencesTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.0.05 CEU/0.5 HrUAN: 0107-0000-24-238-H01-PInitial release date: 07/29/2024Expiration date: 07/29/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death. The GameChangerThe study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEO, SeguridadReferencesMulti-Vitamin StudyNIH Press Release Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of multivitamins.2. Identify implications for healthy patients considering multivitamin use.0.05 CEU/0.5 HrUAN: 0107-0000-24-226-H01-PInitial release date: 07/22/2024Expiration date: 07/22/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?  HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestSally Arif, PharmD, BCCPProfessor of Pharmacy Practice/Clinical Cardiology PharmacistMidwestern University College of PharmacyRush Medical CenterChicago, ILGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching0.05 CEU/0.5 HrUAN: 0107-0000-24-210-H99-PInitial release date: 7/17/2024Expiration date: 7/17/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions. The GameChangerHealth outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics. GuestAnna Garrett, PharmD, BCPSPresident, AnnaGarrett.com ReferenceHow Gut Health Affects Your Whole Body Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the relationship between gut health and systemic conditions.2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.0.05 CEU/0.5 HrUAN: 0107-0000-24-221-H01-PInitial release date: 07/15/2024Expiration date: 07/15/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.  The GameChangerRecurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.  GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health Referenced-Mannose for Prevention of Recurrent Urinary Tract Infection Among WomenA Randomized Clinical Trial Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs.2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.0.05 CEU/0.5 HrUAN: 0107-0000-24-220-H01-PInitial release date: 07/08/2024Expiration date: 07/08/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In this week's episode of GameChangers, we focus on how pharmacists can prevent weight-based dosing errors. Listen in to learn more about:Which body weights to use for which medication-based dosingThe four different scales of weight“Normal” weights for kidsThe Rule of 5 for dosing pediatric patientsWhat the formula is for switching from pediatric dosing to adult dosingThe definition of “Patient first language” The GameChangerToo often, health care providers don't dose medications based on weight. The pharmacist should be ensuring doses are correct based on patient weight. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health Jake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadStephanie Weightman, PharmD, BCPS, BCPPS, BCEMPClinical Pharmacy ManagerPerfecting PedsReferencePediatric Weight is Crucial to Perfecting the DoseUpdated antimicrobial dosing recommendations for obese patients Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss strategies to verify weight-based dosing accuracy to improve patient safety and therapeutic outcomes.2. Explain appropriate dosing adjustments for commonly prescribed antibiotics in pediatric patients and patients with obesity.0.05 CEU/0.5 HrUAN: 0107-0000-24-208-H01-PInitial release date: 06/24/2024Expiration date: 06/24/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Today's episode is an absolute must-listen to. The FDA's decision to approve the drug, Mifepristone, has been escalated in a lawsuit to the U.S. Supreme Court. And, last week, in a unanimous 9-0 decision, the U.S. Supreme Court rejected the challenge to the drug's approval. Today on our podcast, we are answering what exactly is happening with the drug Mifepristone, the legal challenges associated with this medication, and how this U.S. Supreme Court ruling directly impacts pharmacists today.Regardless of your position on this topic, knowing and understanding the history and why the mifepristone conversation is happening is critical.By the time you finish listening, you'll be inspired to take immediate action to join your local and state-level pharmacy association. For more resources, including links to the discussions, education, and training mentioned in the episode, click here to learn more. The GameChangerPharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care. GuestDavid Brushwood, RPh, JDSenior LecturerUniversity of Wyoming ReferenceSupreme Court Document on RulingSupreme Court preserves access to abortion pill Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.2. Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.0.05 CEU/0.5 HrUAN: 0107-0000-24-209-H03-PInitial release date: 06/24/2024Expiration date: 06/24/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Can compassion and empathy be learned? Can it be taught? The evidence suggests that the answer to both of these questions is yes, and yet as preceptors, we interact with student pharmacists and pharmacy residents who are wide-ranging in their abilities and comfort-level when it comes to fostering impactful patient care interactions.In this episode, explore the value (and challenges) of incorporating strategies that model and teach empathy and compassion - for your patients, your learners, and for you. HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestKate Cozart, Med, PharmD, BCPS, BCGP, BCACPClinical Pharmacist Practitioner, Primary CareResidency Program CoordinatorVA Tennessee Valley Healthcare System (TVHS)Clarksville, TNGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Review evidence that compassionate and empathetic patient care positively impacts patients' healthcare experience.2. Identify strategies preceptors can model to help pharmacy learners deliver more compassionate and empathetic care.0.05 CEU/0.5 HrUAN: 0107-0000-24-191-H99-PInitial release date: 6/19/2024Expiration date: 6/19/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

In this week's GameChangers we explore the emerging role of colchicine in the secondary prevention of cardiovascular disease. Drs. Wall and Boyd discuss colchicine's anti-inflammatory benefits, the challenges posed by side effects and drug interactions, and the latest research shaping its future in clinical practice. The GameChangerColchicine shows potential for secondary prevention in cardiovascular disease due to its anti-inflammatory properties, but its clinical use is limited by gastrointestinal side effects and drug interactions.  HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMathew Boyd, PharmDClinical Pharmacist, Unity Point ReferenceMeta-AnalysisClear Synergy Study Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the potential benefits of colchicine in secondary prevention of cardiovascular disease based on its anti-inflammatory properties.2. Discuss the limitations of colchicine use in clinical practice, including gastrointestinal side effects and drug interactions.0.05 CEU/0.5 HrUAN: 0107-0000-24-190-H01-PInitial release date: 06/17/2024Expiration date: 06/17/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

This week's GameChangers explores the transformative impact of continuous glucose monitors (CGMs) on diabetes care. Discover the latest advancements in CGM technology, current ADA recommendations, and practical tips for patient education. The GameChangerCGM technology is constantly changing. The devices are smaller, more user-friendly, and easier to integrate into daily life, thereby improving patient adherence and outcomes. GuestJennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity of South Carolina College of Pharmacy ReferenceADA Info on CGMsAACE Guidelines Update on CGMs Interested in additional Diabetes and CGM pharmacy education?Enroll in Guardian of the Glucose Galaxy: The Rise of CGMsDuring this 1-hour CE, we will cover hot topics such as:The evolution of Continuous Glucose Monitors (CGMs)The impact of CGMs in improving health, clinical outcomes, and quality of life for persons with diabetesThe use of CGMs to manage diabetes across patient populationsThe role of pharmacy teams in managing people with diabetesThe opportunity to integrate CGM devices into practicePharmacists Enroll HerePharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the principles and applications of continuous glucose monitors (CGMs) and summarize current recommendations for their use in diabetes management.2. Discuss how to educate patients on CGM use, including device placement, data interpretation, and troubleshooting common issues.0.05 CEU/0.5 HrUAN: 0107-0000-24-189-H01-PInitial release date: 06/10/2024Expiration date: 06/10/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram